ophiobolin A

Ophiobolin A is a sesterterpenoid fungal metabolite, primarily isolated from *Bipolaris* species, that is being investigated for its potent anti-tumor activity against glioblastoma (GBM) and glioma stem cells (GSCs). Unlike many conventional chemotherapeutics that trigger apoptosis, ophiobolin A induces paraptosis, a non-apoptotic form of programmed cell death characterized by extensive cytoplasmic vacuolization and swelling of the endoplasmic reticulum and mitochondria. This mechanism is particularly valuable for targeting GSCs, which often exhibit resistance to apoptotic pathways. Chemically, it is known to covalently bind to calmodulin, thereby disrupting calcium-dependent signaling processes essential for cancer cell survival and proliferation. Current research efforts, involving institutions such as Texas State University and UT Health San Antonio, are focused on synthesizing C21-derivatives to improve the molecule's metabolic stability and pharmacological profile for clinical application.